These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 21956205

  • 21. miR-182 enhances acute kidney injury by promoting apoptosis involving the targeting and regulation of TCF7L2/Wnt/β-catenins pathway.
    Li H, Ma Y, Chen B, Shi J.
    Eur J Pharmacol; 2018 Jul 15; 831():20-27. PubMed ID: 29733821
    [Abstract] [Full Text] [Related]

  • 22. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
    Takahashi M, Nakamura Y, Obama K, Furukawa Y.
    Int J Oncol; 2005 Dec 15; 27(6):1483-7. PubMed ID: 16273202
    [Abstract] [Full Text] [Related]

  • 23. The Bcl-w promoter is activated by beta-catenin/TCF4 in human colorectal carcinoma cells.
    Lapham A, Adams JE, Paterson A, Lee M, Brimmell M, Packham G.
    Gene; 2009 Mar 01; 432(1-2):112-7. PubMed ID: 19124064
    [Abstract] [Full Text] [Related]

  • 24. Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction.
    Tian W, Han X, Yan M, Xu Y, Duggineni S, Lin N, Luo G, Li YM, Han X, Huang Z, An J.
    Biochemistry; 2012 Jan 17; 51(2):724-31. PubMed ID: 22224445
    [Abstract] [Full Text] [Related]

  • 25. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
    Sarver AL, Li L, Subramanian S.
    Cancer Res; 2010 Dec 01; 70(23):9570-80. PubMed ID: 21118966
    [Abstract] [Full Text] [Related]

  • 26. WWC3 Inhibits Glioma Cell Proliferation Through Suppressing the Wnt/β-Catenin Signaling Pathway.
    Wang Y, Jiang M, Yao Y, Cai Z.
    DNA Cell Biol; 2018 Jan 01; 37(1):31-37. PubMed ID: 29115863
    [Abstract] [Full Text] [Related]

  • 27. The oncogenic role of miR-155 in breast cancer.
    Mattiske S, Suetani RJ, Neilsen PM, Callen DF.
    Cancer Epidemiol Biomarkers Prev; 2012 Aug 01; 21(8):1236-43. PubMed ID: 22736789
    [Abstract] [Full Text] [Related]

  • 28. β-Catenin/TCF4 Complex-Mediated Induction of the NRF3 (NFE2L3) Gene in Cancer Cells.
    Aono S, Hatanaka A, Hatanaka A, Gao Y, Hippo Y, Taketo MM, Waku T, Kobayashi A.
    Int J Mol Sci; 2019 Jul 08; 20(13):. PubMed ID: 31288376
    [Abstract] [Full Text] [Related]

  • 29. The mechanisms of genome-wide target gene regulation by TCF7L2 in liver cells.
    Norton L, Chen X, Fourcaudot M, Acharya NK, DeFronzo RA, Heikkinen S.
    Nucleic Acids Res; 2014 Dec 16; 42(22):13646-61. PubMed ID: 25414334
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. TCF7L2 silencing results in altered gene expression patterns accompanied by local genomic reorganization.
    Brown MA, Dotson GA, Ronquist S, Emons G, Rajapakse I, Ried T.
    Neoplasia; 2021 Feb 16; 23(2):257-269. PubMed ID: 33422939
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cellular microRNA sensors based on luciferase reporters.
    Connelly CM, Deiters A.
    Methods Mol Biol; 2014 Feb 16; 1095():135-46. PubMed ID: 24166309
    [Abstract] [Full Text] [Related]

  • 36. BRD4-binding enhancer promotes CRC progression by interacting with YY1 to activate the Wnt pathway through upregulation of TCF7L2.
    Duan B, Zhou X, Zhang X, Qiu F, Zhang S, Chen Y, Yang J, Wang J, Tan W.
    Biochem Pharmacol; 2023 Dec 16; 218():115877. PubMed ID: 37879498
    [Abstract] [Full Text] [Related]

  • 37. MAD2B acts as a negative regulatory partner of TCF4 on proliferation in human dermal papilla cells.
    Yu N, Song Z, Zhang K, Yang X.
    Sci Rep; 2017 Sep 15; 7(1):11687. PubMed ID: 28916740
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand.
    Boj SF, van Es JH, Huch M, Li VS, José A, Hatzis P, Mokry M, Haegebarth A, van den Born M, Chambon P, Voshol P, Dor Y, Cuppen E, Fillat C, Clevers H.
    Cell; 2012 Dec 21; 151(7):1595-607. PubMed ID: 23260145
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.